Imunon, Inc. filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-06-30. Between them they name 2 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Jeffrey Church, Chief Financial Officer, effective 2026-07-01
Retirement of interim Chief Financial Officer On June 29, 2026, Jeffrey Church informed Imunon, Inc. (the "Company") of his intent to retire from the position of interim Chief Financial Officer (a position he has held since January of 2026), effective July 1, 2026 (the "Retirement Date").
Appointed: Josh Blacher, Chief Financial Officer, effective 2026-07-01
As a result of Mr. Church's retirement, effective July 1, 2026, the Company appointed Josh Blacher to serve as the Company's new interim Chief Financial Officer under a master services agreement (the "Agreement"), dated June 24, 2026, between the Company and Danforth Health, Inc., a financial advisory services firm ("Danforth").
Appointed: Josh Blacher
Mr. Blacher will serve as the Company's principal financial officer and principal accounting officer.
Find people with the same kind of experience as the Chief Financial Officer at Imunon, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Imunon, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Imunon, Inc. is in the news or changes leadership.
Get an alert when Imunon, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Imunon, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.